Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase I trial of Ad.hIFN-beta gene therapy for glioma.

A phase I trial of Ad.hIFN-beta gene therapy for glioma. Mol Ther. 2008 Mar; 16(3):618-26.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.